Avior Wealth Management LLC Sells 8,585 Shares of iShares U.S. Pharmaceuticals ETF $IHE

Avior Wealth Management LLC trimmed its holdings in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 66.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 4,271 shares of the company’s stock after selling 8,585 shares during the period. Avior Wealth Management LLC’s holdings in iShares U.S. Pharmaceuticals ETF were worth $423,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of IHE. Western Wealth Management LLC purchased a new position in shares of iShares U.S. Pharmaceuticals ETF in the first quarter worth $150,000. NewEdge Advisors LLC boosted its position in shares of iShares U.S. Pharmaceuticals ETF by 45.1% during the first quarter. NewEdge Advisors LLC now owns 1,397 shares of the company’s stock valued at $121,000 after buying an additional 434 shares during the last quarter. Bank of America Corp DE boosted its position in shares of iShares U.S. Pharmaceuticals ETF by 2.8% during the first quarter. Bank of America Corp DE now owns 456,606 shares of the company’s stock valued at $39,579,000 after buying an additional 12,565 shares during the last quarter. Sunbelt Securities Inc. increased its holdings in iShares U.S. Pharmaceuticals ETF by 14.3% in the 1st quarter. Sunbelt Securities Inc. now owns 960 shares of the company’s stock worth $83,000 after buying an additional 120 shares in the last quarter. Finally, Cetera Investment Advisers increased its holdings in iShares U.S. Pharmaceuticals ETF by 675.4% in the 1st quarter. Cetera Investment Advisers now owns 109,471 shares of the company’s stock worth $9,489,000 after buying an additional 95,353 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Stock Performance

Shares of NYSEARCA:IHE opened at $102.47 on Friday. The firm has a market cap of $1.64 billion, a price-to-earnings ratio of 17.75 and a beta of 0.48. The business has a 50-day simple moving average of $98.00 and a two-hundred day simple moving average of $91.56. iShares U.S. Pharmaceuticals ETF has a fifty-two week low of $65.60 and a fifty-two week high of $105.02.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.